The higher the tumor volume in the RLS40 control subgroups, the lower the percentage of FAS+ neutrophil population: 20.6 ± 1.9% in the RLS40Low subgroup and 1.4 ± 0.1 and 2.8 ± 0.3 in RLS40Med and RLS40High subgroups, respectively (Figure 5A). This evidence concerns the gene FAS and neoplasm.